Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7-30. doi: 10.3322/caac.21442. pmid: 29313949.
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87-108. doi: 10.3322/caac.21262. pmid: 25651787.
Global Burden of Disease Cancer C, Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, et al. The Global Burden of Cancer 2013. JAMA Oncol. 2015;1(4):505-27. doi: 10.1001/jamaoncol.2015.0735. pmid: 26181261.
Smith RA, Manassaram-Baptiste D, Brooks D, Doroshenk M, Fedewa S, Saslow D, et al. Cancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screening. CA Cancer J Clin. 2015;65(1):30-54. doi: 10.3322/caac.21261. pmid: 25581023.
Haas JS, Sprague BL, Klabunde CN, Tosteson AN, Chen JS, Bitton A, et al. Provider Attitudes and Screening Practices Following Changes in Breast and Cervical Cancer Screening Guidelines. J Gen Intern Med. 2016;31(1):52-9. doi: 10.1007/s11606-015-3449-5. pmid: 26129780.
Siu AL, Force USPST. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2016;164(4):279-96. doi: 10.7326/M15-2886. pmid: 26757170.
Tonelli M, Connor Gorber S, Joffres M, Dickinson J, Singh H, Lewin G, et al. Recommendations on screening for breast cancer in average-risk women aged 40-74 years. CMAJ. 2011;183(17):1991-2001. doi: 10.1503/cmaj.110334. pmid: 22106103.
Esherick JS, Clark DS, Slater ED, Gonzales R. Current Practice Guidelines in Primary Care: 2016: McGraw-Hill Medical Publishing Division; 2016.
Sawaya GF, Smith-McCune K. Cervical Cancer Screening. Obstet Gynecol. 2016;127(3):459-67. doi: 10.1097/AOG.0000000000001136. pmid: 26855089.
Fowler CI, Saraiya M, Moskosky SB, Miller JW, Gable J, Mautone-Smith N. Trends in Cervical Cancer Screening in Title X-Funded Health Centers - United States, 2005-2015. MMWR Morb Mortal Wkly Rep. 2017;66(37):981-5. doi: 10.15585/mmwr.mm6637a4. pmid: 28934183.
Leggett BA, Hewett DG. Colorectal cancer screening. Intern Med J. 2015;45(1):6-15. doi: 10.1111/imj.12636. pmid: 25582937.
Bray C, Bell LN, Liang H, Collins D, Yale SH. Colorectal Cancer Screening. WMJ. 2017;116(1):27-33. pmid: 29099566.
Schreuders EH, Ruco A, Rabeneck L, Schoen RE, Sung JJ, Young GP, et al. Colorectal cancer screening: a global overview of existing programmes. Gut. 2015;64(10):1637-49. doi: 10.1136/gutjnl-2014-309086. pmid: 26041752.
Vernon SW, Murphy CC, McQueen A. Colorectal cancer screening. Psycho-Oncology. New York: Oxford University Press; 2015.
Imperiale TF, Ransohoff DF, Itzkowitz SH, Levin TR, Lavin P, Lidgard GP, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;370(14):1287-97. doi: 10.1056/NEJMoa1311194. pmid: 24645800.
Knudsen AB, Zauber AG, Rutter CM, Naber SK, Doria-Rose VP, Pabiniak C, et al. Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force. JAMA. 2016;315(23):2595-609. doi: 10.1001/jama.2016.6828. pmid: 27305518.
Sung JJ, Ng SC, Chan FK, Chiu HM, Kim HS, Matsuda T, et al. An updated Asia Pacific Consensus Recommendations on colorectal cancer screening. Gut. 2015;64(1):121-32. doi: 10.1136/gutjnl-2013-306503. pmid: 24647008.
Drazer MW, Huo D, Eggener SE. National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening. J Clin Oncol. 2015;33(22):2416-23. doi: 10.1200/JCO.2015.61.6532. pmid: 26056181.
Catalona WJ. Prostate Cancer Screening. Med Clin North Am. 2018;102(2):199-214. doi: 10.1016/j.mcna.2017.11 .001. pmid: 29406053.
Eastham J. Prostate cancer screening. Investig Clin Urol. 2017;58(4):217-9. doi: 10.4111/icu.2017.58.4.217. pmid: 28681029.
Bibbins-Domingo K, Grossman DC, Curry SJ. The US Preventive Services Task Force 2017 Draft Recommendation Statement on Screening for Prostate Cancer: An Invitation to Review and Comment. JAMA. 2017;317(19):1949-50. doi: 10.1001/jama.2017.4413. pmid: 28397958.
Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, et al. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol. 2014;65(1):124-37. doi: 10.1016/j.eururo.2013.09.046. pmid: 24207135.
Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M, et al. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 2017;71(4):618-29. doi: 10.1016/j.eururo.2016.08.003. pmid: 27568654.
de Koning HJ, Meza R, Plevritis SK, ten Haaf K, Munshi VN, Jeon J, et al. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med. 2014;160(5):311-20. doi: 10.7326/M13-2316. pmid: 24379002.
Tanoue LT, Tanner NT, Gould MK, Silvestri GA. Lung cancer screening. Am J Respir Crit Care Med. 2015;191(1):19-33. doi: 10.1164/rccm.201410-1777CI. pmid: 25369325.
Infante M, Cavuto S, Lutman FR, Passera E, Chiarenza M, Chiesa G, et al. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography. Am J Respir Crit Care Med. 2015;191(10):1166-75. doi: 10.1164/rccm.201408-1475OC. pmid: 25760561.